U.S. Chemicals Stock News

Why ArcBest View matters for ArcBest (ARCB) shareholders ArcBest (ARCB) has launched ArcBest View, a digital logistics platform that centralizes shipment visibility, booking, management, and reporting. This gives investors a fresh operational development to consider when assessing the stock. See our latest analysis for ArcBest. The launch of ArcBest View comes as momentum builds in the stock, with a 1-month share price return of 8.64%, a 90-day share price return of 30.73%, and a 1-year total...

Activist pressure and new technology investment put H.B. Fuller in focus H.B. Fuller (FUL) is drawing fresh investor attention after Ancora Holdings publicly opposed a potential acquisition of Advanced Medical Solutions Group and the company announced an investment in VerdaFresh oxygen barrier technology. See our latest analysis for H.B. Fuller. The recent 10.9% 7 day share price return and 6.9% 1 month share price return, against a 1 year total shareholder return of 18.8%, suggest momentum...

Replimune Group, Inc. recently announced that, following collaborative discussions, it has aligned with the U.S. FDA on a prioritized resubmission and review path for its RP1 (vusolimogene oderparepvec) Biologics License Application in combination with nivolumab for patients with advanced melanoma who have progressed on prior anti-PD-1 therapy. This regulatory step is significant because RP1, an engineered herpes simplex virus designed to enhance tumor killing and immune activation, targets...

Recent performance snapshot Stagwell (STGW) has attracted attention after a period in which its stock showed varied short-term returns, including approximately 7.7% over the past week, 10.2% over the past month, and 41.6% over the past 3 months. See our latest analysis for Stagwell. With the share price at $7.01, Stagwell’s recent 48.2% year to date share price return and 68.5% 1 year total shareholder return suggest momentum has been building after a softer 3 year total shareholder return of...

In May 2026, Ardelyx reported that first-quarter 2026 revenue grew 58% year over year, supported by increasing use of IBSRELA, its IBS-C therapy and the only approved NHE3 inhibitor in its class. An interesting angle is that AI-driven stock rankings have started spotlighting Ardelyx, citing IBSRELA’s differentiated mechanism and suggesting growing investor attention to its commercial trajectory. Next, we’ll examine how Ardelyx’s strong IBSRELA-driven revenue growth may influence the...

With markets fixated on the next jobs report, wage trends, inflation pressures and a jumpy bond market, bank stocks are sitting right in the crosshairs of shifting rate expectations and funding costs. For investors, that mix can offer both openings and risks, depending on how each institution is positioned. This article highlights 3 stocks from a U.S. bank and financials screener that appear positively exposed to the current macro story, based on size and balance sheet quality. The discussion...

Valuation snapshot and recent performance S&T Bancorp (STBA) has drawn investor interest recently as the stock trades around $45.09, with an indicated intrinsic discount of about 34% and a value score of 3, prompting closer attention to its fundamentals. See our latest analysis for S&T Bancorp. Recent trading has been steadily positive, with a 90 day share price return of 5.77% and year to date share price return of 14.91%. At the same time, the 3 year total shareholder return of 78.83% and 5...

Raised guidance and alternative proteins put Performance Food Group in focus Performance Food Group (PFGC) recently raised its full year 2026 revenue guidance after emphasizing its focus on alternative food technology and sustainable proteins, drawing attention from investors watching the stock’s recent move. See our latest analysis for Performance Food Group. Investor interest around the updated 2026 revenue guidance and focus on alternative and sustainable proteins has coincided with...

In recent days, Toast has attracted increased attention as analysts raised their earnings estimates, leading to an improved outlook and a Zacks Rank #2 rating. This earnings upgrade story underscores how shifting analyst expectations around Toast’s profit trajectory can materially influence how investors view the business. We’ll now examine how these upgraded earnings expectations and stronger outlook could influence Toast’s existing investment narrative and risk profile. Uncover the next...

Nakamoto Inc. ( NASDAQ:NAKA ) shareholders (or potential shareholders) will be happy to see that the Chairman & CEO...

Recent share performance and business snapshot Select Water Solutions (WTTR) has drawn fresh attention after a period of stronger share performance, with the stock up over the past month and past 3 months while still showing some short term pullbacks. The company focuses on water management solutions for the US energy sector across three segments: Water Infrastructure, Water Services, and Chemical Technologies. It generated US$1,398.918 million in revenue and US$21.59 million in net...

Recent performance snapshot and what triggered a closer look StepStone Group (STEP) has come onto investors’ radar after a mixed stretch in its stock performance, with shares down over the past week and month but showing a gain over the past 3 months. See our latest analysis for StepStone Group. At a share price of US$49.31, StepStone Group has seen short term share price momentum fade, with the 7 day and 30 day share price returns down 8.24% and 6.51% respectively. At the same time, the 3...

Recent performance snapshot American Assets Trust (AAT) has attracted investor attention after a period of steady trading, with the stock recently closing at US$23.30 and posting positive returns over the past month and past 3 months. See our latest analysis for American Assets Trust. At around US$23.30 per share, American Assets Trust has recently seen momentum build, with a 30-day share price return of 12.13% and a 90-day share price return of 19.30%. This is set against a 1-year total...

Near term performance and recent stock move Ovintiv (OVV) has drawn investor attention after a mixed stretch in the stock, with the price up 0.4% in the latest session but down about 4.6% over the past week. Over the past month the stock is down roughly 7.9%, while the past 3 months show a gain of about 8.2%, alongside a year to date total return near 38.4% and a 1 year total return around 57.5%. See our latest analysis for Ovintiv. Recent trading has cooled after a strong run, with the share...

In May 2026, MakeMyTrip Limited reported fourth-quarter and full-year results showing year-on-year revenue growth to US$250.12 million and US$1.04 billion respectively, alongside lower net income, while also completing a long-running US$127.56 million share repurchase program covering 4.03% of its shares. An interesting twist is that despite the earnings pressure partly linked to West Asia-related travel disruptions, MakeMyTrip continued buying back shares, signaling management’s willingness...

In late May 2026, Synopsys reported second-quarter revenue of US$2,275.99 million with sharply lower net income of US$17.11 million, raised its full-year revenue and EPS guidance, expanded its AI-powered EDA and IP collaboration with Samsung Foundry across advanced 2nm and 3DIC nodes, and added Elliott’s Jesse Cohn to its board. Together, these developments highlight Synopsys’ twin pressures and opportunities: integrating Ansys and new AI offerings while an activist-backed board pushes for...

Moody's stock performance snapshot Moody's (MCO) has drawn investor attention after recent share price moves, with the stock up 0.6% over the past day and 0.9% over the past week, while showing declines over the past month and past 3 months. At a last close of US$453.25 and a market value of about US$79.2b, the company sits within the diversified financials sector, combining a large credit ratings operation with a sizable analytics and risk solutions business. See our latest analysis for...

In recent months, Arista Networks reported strong revenue growth from its AI-optimized Ethernet networking portfolio and modestly raised its near-term and full-year revenue guidance, citing expanding deployments across more than 100 advanced AI customers despite ongoing supply chain pressures on margins. A key insight is that management expects AI-related revenues to more than double in 2026 as cloud and enterprise clients invest heavily to ease AI data bottlenecks, underscoring Arista’s...

Why Grab’s Superbank Move Matters for Investors Grab Holdings (GRAB) is drawing attention after announcing plans to consolidate PT Super Bank Indonesia Tbk, as a share transfer to GXS Bank lifts its combined stake above 50% and brings Superbank into Grab’s Financial Services segment. See our latest analysis for Grab Holdings. Despite the Superbank announcement, the stock has faced pressure, with the share price down 30.31% year to date and the 1 year total shareholder return declining 27.01%,...

Why Amcor (AMCR) Is Back on Income Investors’ Radar Amcor (AMCR) has drawn fresh attention after joining a top high yield Dividend Aristocrats list, reporting fiscal Q3 earnings ahead of expectations, and attracting mixed but engaged analyst commentary on its outlook. See our latest analysis for Amcor. Recent attention around Amcor’s Dividend Aristocrat status and fiscal Q3 outperformance comes against a mixed backdrop, with the stock’s 30 day share price return up 2.83% while its 1 year...

Why Reddit’s latest results matter for investors Reddit (RDDT) is back in focus after a strong quarterly report highlighted 69% year over year revenue growth to US$663.4 million and a 31% net income margin, which has renewed attention on its stock performance. The quarter also showcased Reddit’s growing role in AI data licensing, with Google reportedly paying for access to its content. Commentators have pointed to these fundamentals as a key driver of recent bullish sentiment. See our latest...

General Dynamics recently secured a US$106 million task order from the U.S. Space Systems Command for long-term sustainment support and a US$39.19 million Navy personnel-system contract modification, reinforcing its role in critical defense infrastructure and secure communications. These awards, combined with solid cash generation, shareholder returns, and a robust contract backlog, underline how General Dynamics converts consistent contract wins into durable revenue visibility and...

Thermon Group Holdings stock snapshot Thermon Group Holdings (THR) has drawn fresh attention after recent share price moves, with the stock last closing at $61.14. Investors are weighing this level against the company’s multi-region industrial heating and process solutions business. See our latest analysis for Thermon Group Holdings. Despite the latest 1-day share price decline of 8.49% to $61.14 and a softer 7-day share price return of 6.95% in the red, Thermon Group Holdings still has a...

Adaptive Biotechnologies recently announced that its NGS-based clonoSEQ test for measurable residual disease was featured in 33 presentations, including a plenary session and 14 oral talks, at the 2026 ASCO and EHA meetings, underscoring its use across multiple myeloma, CLL, ALL, and lymphoma in both research and clinical care. An interesting angle for investors is how clonoSEQ’s FDA clearance, Medicare coverage, CE-mark under EU IVDR, and growing use as an MRD endpoint in interventional...